Efficacy and safety of nafamostat mesilate for sepsis (EASNMS): study protocol for a multicenter randomized controlled trial.

Yang H, Feng J, Ma Y, Ma X, Li X, EASNMS investigators

Open source

DOI
10.1186/s13063-025-08979-4
Published
2025 Jul 29
Container
Trials
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13063-025-08979-4,
  title = {Efficacy and safety of nafamostat mesilate for sepsis (EASNMS): study protocol for a multicenter randomized controlled trial.},
  author = {Yang H and Feng J and Ma Y and Ma X and Li X and EASNMS investigators},
  year = {2025},
  journal = {Trials},
  doi = {10.1186/s13063-025-08979-4},
  url = {https://doi.org/10.1186/s13063-025-08979-4}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of nafamostat mesilate for sepsis (EASNMS): study protocol for a multicenter randomized controlled trial.
AU  - Yang H
AU  - Feng J
AU  - Ma Y
AU  - Ma X
AU  - Li X
AU  - EASNMS investigators
PY  - 2025
JO  - Trials
DO  - 10.1186/s13063-025-08979-4
UR  - https://doi.org/10.1186/s13063-025-08979-4
ER  - 

APA

H, Y., J, F., Y, M., X, M., X, L., & investigators, E. (2025). Efficacy and safety of nafamostat mesilate for sepsis (EASNMS): study protocol for a multicenter randomized controlled trial.. Trials. https://doi.org/10.1186/s13063-025-08979-4

Source records